Trastuzumab-related cardiac events in the treatment of early breast cancer Georgeta FriedTslil RegevMor Moskovitz Review 24 October 2013 Pages: 1 - 7
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model Giselle V. RipollJuan GaronaDaniel F. Alonso Preclinical study Open access 12 October 2013 Pages: 9 - 18
MicroRNA signatures in hereditary breast cancer Rosa Murria EstalSarai Palanca SuelaPascual Bolufer Gilabert Preclinical study 16 October 2013 Pages: 19 - 30
Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer Louise Maymann NitzeElisabeth Douglas GalsgaardSvetlana Panina Preclinical study Open access 22 October 2013 Pages: 31 - 44
Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells Kyle K. PayneChristine K. ZoonMasoud H. Manjili Preclinical Study 25 October 2013 Pages: 45 - 57
Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer Lauren S. JammalloCynthia L. MillerAlphonse G. Taghian Clinical Trial 12 October 2013 Pages: 59 - 67
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy S. OhnoL. W. C. ChowM. Toi Clinical Trial Open access 12 October 2013 Pages: 69 - 80
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients Anja WeltMitra TewesStefan Kasper Clinical Trial 12 October 2013 Pages: 81 - 88
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA) David MilesJosé BaselgaSandra M. Swain Clinical trial Open access 16 October 2013 Pages: 89 - 99
Preference weights for chemotherapy side effects from the perspective of women with breast cancer I. KuchukN. BouganimM. Clemons Clinical trial 16 October 2013 Pages: 101 - 107
Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer L. EckhoffA. S. KnoopM. Ewertz Clinical trial 17 October 2013 Pages: 109 - 118
Favorable modulation of benign breast tissue and serum risk biomarkers is associated with >10 % weight loss in postmenopausal women Carol J. FabianBruce F. KimlerStephen D. Hursting Clinical trial 19 October 2013 Pages: 119 - 132
Breast cancer risk among women with long-standing lactation and reproductive parameters at low risk level: a case–control study in Northern Tanzania Irmgard JordanAntje HebestreitMichael B. Krawinkel Epidemiology 20 November 2010 Pages: 133 - 141
Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials J. F. HiltonN. BouganimM. Clemons Epidemiology 11 October 2013 Pages: 143 - 151
Long-term surveillance mammography and mortality in older women with a history of early stage invasive breast cancer Diana S. M. BuistJaclyn L. F. BoscoThe Breast Cancer Outcomes in Older Women (BOW) Investigators Epidemiology 11 October 2013 Pages: 153 - 163
Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: Are there differences before and after age 40? Erica T. WarnerGraham A. ColditzRulla M. Tamimi Epidemiology 18 October 2013 Pages: 165 - 175
The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation Adriana ValentiniJan LubinskiThe Hereditary Breast Cancer Clinical Study Group Epidemiology 18 October 2013 Pages: 177 - 185
Validation of Rosner–Colditz breast cancer incidence model using an independent data set, the California Teachers Study B. A. RosnerG. A. ColditzL. Bernstein Epidemiology Open access 26 October 2013 Pages: 187 - 202
Prospective clinical experience with research biopsies in breast cancer patients Ines Vaz-LuisCatherine A. ZeghibeNancy U. Lin Brief Report Open access 11 October 2013 Pages: 203 - 209
Distinct nuclear receptor expression in stroma adjacent to breast tumors Kevin C. KnowerAshwini L. ChandColin D. Clyne Brief Report 11 October 2013 Pages: 211 - 223
Erratum to: CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy Wendy A. TeftInna Y. GongRichard B. Kim Erratum 28 September 2013 Pages: 225 - 225
